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Compensatory renal growth: modulation by calcium and 1,25-(OH)2D3.
To further elucidate the mechanisms by which compensatory renal
growth (CRG) can be influenced by calcium and calcium regulating
hormones, the influence of dietary calcium and phosphorus, parathy-
roid hormone (PTH) or l,25-dihydroxycholecalciferol (l.25-(OH)2D3)
was evaluated in unilaterally nephrectomized (tJNI-NX) rats. These
animals were sacrificed three days after UNT-NX and CRG of the
remaining kidney was assessed by kidney WI, RNA and DNA gains, and
by 3H-thymidine incorporation. The degree of CR0 was enhanced in
animals given a low dietary calcium and, conversely, was decreased in
those receiving a phosphorus—poor diet. In thyroparathyroidectomized
(TPTX) rats, PTH administration resulted in a dose proportional
stimulation of CR0. When I ,25-(OH),D3 was given to vitamin D
deficient animals, the degree of CR0 was enhanced in a dose propor-
tional manner. In another experiment, TPTX-vitamin D deficient rats
were given the same amount of l,25-(OH).D3 by miniosrnotic pump
infusion. In these animals, dietary calcium restriction, instead of
stimulating, inhibited CRG. From these observations we conclude that
calcium and calcium regulating hormones modulate CR0, and hypoth-
esize that the effects observed are mediated through changes in cell
calcium.
It is a well established fact that the removal of one kidney
results in a compensatory renal growth (CRG) of the other
kidney [1]. This adaptation of the remaining kidney tissue
proceeds by both hyperplasia and hypertrophy, mainly at the
level of the tubular epithelium [I, 21. In addition to these
anatomic changes, multiple biochemical alterations as well as
the adaptation of a variety of renal functions have been de-
scribed [1, 31.
The precise stimuli that trigger these adaptive changes are
largely unknown. However, many observations suggest the
presence of circulating growth factors that may stimulate
(renotropins) or inhibit (antirenotropins) kidney growth [4]. The
mechanism by which these substances, considered as regula-
tors of kidney growth, act is unknown. Besides these regula-
tors, a number of factors have been shown to modulate the
extent of the growth response: age [5, 6], growth hormone [7],
testosterone [8], thyroid hormone [9] or adrenal steroids [10]
have all been reported to stimulate the degree of CRG. These
factors may act at least in part by affecting the state of
anabolism of the whole organism and, in this regard, the
specificity of their effect on CRG might be questionable. Other
factors, such as the diabetic state [11], high protein diet [12, 13]
and an acid load [14] may also enhance the degree of the CRG
response, but it is noteworthy that these factors also enhance
normal kidney growth.
We have recently described that feeding a low calcium diet
leads to an important enhancement of CRG [15]. This effect of
dietary calcium may be considered specific with regard to CRG,
since dietary calcium has no influence on body growth or
normal kidney growth. In addition, parathyroid hormone (PTH)
could mimick, at least partly, the effect of a low dietary
calcium.
The purpose of the present study is to define further the
mechanisms by which alterations of calcium metabolism and
calcium related hormones affect CR0. More specifically, we
attempt to define the respective roles of calcium, phosphorus,
parathyroid hormone and I ,25-(OH)2D1 in the stimulation of
CRG by dietary calcium restriction.
Methods
Male Wistar rats were obtained from Charles River laborato-
ries (St-Constant, Quebec, Canada) and each experiment was
so designed that the animals weighed 105 15 g at the time of
nephrectomy (UNI-NX). Upon reception, animals were fed a
synthetic diet' whose calcium and phosphorus contents had
been adjusted to 1.0% and 0.8%, respectively, by the addition
of calcium gluconate and of KH2PO4/ K2HPO4. All animals had
free access to demineralized water and, except otherwise
stated, received a daily dose of 10 IU of vitamin D3 with their
food. For each given experiment, all rats had access to the same
amount of food, and those eating less than 90% of what was
given were excluded from the study.
After an equilibration period of at least one week, animals
underwent a right nephrectomy under light ether anesthesia,
through a right flank incision. The excised kidney was placed in
normal saline, dccapsulated, gently blotted, weighed and cut
transversally into halves. One half was put into 10 muter of 10%
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'The basic diet was composed of 65% dextrose, 19% vitamin free
casein, 10% corn oil, 3% cellulose, 0.2% choline and 0.2% cystine, to
which was added a mineral mixture providing all essential minerals
(except calcium and phosphorus). Hydrosoluble and liposoluble vita-
mins (except vitamin D) were mixed to the diet.
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formol and later processed for histological examination. The
other was weighed, put into 10 mliter of distilled water and
homogenized. DNA content of kidney tissue was determined on
frozen aliquots of homogenates according to the method of
Burton [16]. RNA content was assessed by measuring the
ultraviolet absorption after alkaline hydrolysis of nucleic acids
precipitate [17, 18]. Details of the manipulations performed
between UNI-NX and sacrifice will be given in the sections
dealing with individual experiments.
Animals were sacrificed three days after nephrectomy. Two
hr before sacrifice, 50 Ci of 3H Thymidine (78.1 Ci/mmole;
New England Nuclear, Boston, Massachusetts, USA), dis-
solved in 0.3 mliter of isotonic saline was injected slowly by a
tail vein. Two hr later, rats were sacrificed by aortic puncture
under pentobarbital anesthesia. The left kidney was processed
in exactly the same way as the right one except that, in addition,
incorporation of 3H thymidine into DNA was assessed by
measuring the radioactivity of the acid insoluble fraction of the
homogenate. Since free thymidine was washed out during the
procedure [18], the measured radioactivity reflects total rate of
thymidine incorporated into DNA. Plasma calcium was mea-
sured by atomic absorption spectrophotometry and plasma
phosphorus by the method of Chen, Tonbara and Huber [19].
Kidney wt gain, DNA and RNA accretion, as well as 3H
thymidine incorporation were chosen as indices of CRG. Ex-
cept for the radioactivity measurements, the degree of CRG (as
assessed by a given parameter) has been calculated by the
following formula:
Left kidney — Right kidneyCRG(%) = x 100
Right kidney
Since no difference has been found between the right and the
left kidney with regard to the parameters studied, the formula
assesses the percent changes that have occurred during the time
interval between nephrectomy and sacrifice. Results are shown
as mean SEM and statistics were performed using variance
analysis or unpaired t-test when appropriate.
Effects of alterations of calcium and phosphorus intakes on
CRG
After equilibration and UNI-NX, groups of animals were
pair-fed diets containing either 0.1, 0.6 or 1.1% calcium and
0.8% phosphorus until sacrifice three days later. The effect of
dietary phosphate on CRG was assessed by feeding rats,
between UNI-NX and sacrifice, a diet containing 1% calcium
and either 0.0, 0.5 or 1.0% phosphorus.
Effect of PTH on CRG in thyroparathyroidectomized animals
Rats were surgically thyroparathyroidectomized (TP1'X) un-
der light ether anesthesia two weeks before UNI-NX. Only
animals whose plasma calcium was less than 6 mgIlOO mliter
after an overnight fast were selected for the experiment. Thy-
roid hormone supplementation was thereafter provided by 1 g
of L-thyroxine (Sigma, St. Louis, Missouri, USA) given sub-
cutaneously three times a week. From the time of UNI-NX to
sacrifice three days later, parathyroid hormone (Bovine PTH
(1-34), 9,500 lU/mg, Bachem, California, USA) was infused at
doses of 0, 10, 20, 40, or 80 lU/day. The peptide was dissolved
in a solution containing 0.04M acetic acid, 5% serum albumin
and 150 mi NaCl and infused by intraperitoneally implanted
osmotic minipumps (Alzet, Palo Alto, California, USA), de-
signed to accurately deliver 1 microliter of fluid per hour.
Effect of 1,25-(OH)2D3 on CRG in vitamin D deficient rats
The procedure to obtain vitamin D deficient rats began one
week after their conception by feeding the mothers a vitamin D
deficient diet. This same diet that contained 1% calcium and
0.8% phosphate was continued during the lactation period and
thereafter given to the offsprings until the end of the experi-
ment. At the time of nephrectomy, osmotic minipumps were
put into the peritoneal cavity, in order to deliver as
1 ,25-(OH)2D3 at rates ranging from 0 to 80 pmoles per day. The
vehicle was composed of a mixture of ethanol, propylene glycol
and isotonic saline at a ratio of 1:16:3.
Effect of dietary calcium on CRG in vitamin D deficient
TPTX animals
Vitamin D deficient rats obtained as described above, were
thyroparathyroidectomized (TPTX) and given a replacement
dose of thyroxine. From the day before TPTX to the end of the
experiment they were then given 15 pmoles per day of
1 ,25-(OH)2D3 subcutaneously in order to maintain normal plas-
ma calcium. After UNI-NX, rats were fed a diet containing
1.0% phosphorus and either a calcium free or 1.0% calcium
diet.
Effect of Verapamil on RCG
This experiment was conducted according to methodology
described previously [15]. Briefly, rats were equilibrated and,
from the time of nephrectomy to the end of the experiment,
were fed either a 1.1 or a 0.1% calcium diet. In each of these
groups half of the animals were given verapamil. This calcium—
entry blocker was given on food twice daily, beginning at a daily
dose of 1 mg for four days which was increased at 1.5 mg for
another four days. Rats were sacrificed eight days after
nephrectomy.
Results
Influence of calcium and phosphorus content of the diet on
CRG
Figure 1 illustrates the inverse relationship between CRG and
dietary calcium, confirming previously published data [15].
Three days after UNI-NX, kidney wt gain, RNA synthesis and
3H thymidine incorporation were higher by 15, 19 and 34%
respectively in animals fed a low dietary calcium when com-
pared to those fed a 1.1% calcium diet. Similar changes were
observed with regard to DNA synthesis although those were
not statistically significant.
The effects of alterations of dietary phosphorus on CRG is
shown in Figure 2. A marked inhibition of CRG was noticeable
in animals fed either a phosphorus free or a 0.5% phosphorus
diet when those were compared to rats fed a 1.0% phosphorus
diet: kidney wt gain, for example, increased by 20.5 1.7% in
animals fed a phosphorus free diet vs. 62.1 5.6% for those
whose dietary phosphorus content was 1.0%. Corresponding
mean increases in RNA and DNA and values of 3H thymidine
incorporation were: 23.3 0.6% vs. 72.6 6.8%, 11.3 2.0%
vs. 22.9 3.7% and 197 20 vs. 823 87 DPM x 103/kidney.
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In another experiment where CR0 was assessed 15 days after
UNI-NX, the percentage increase in kidney wt was 79.2
3.2% in animals fed a 0.4% phosphorus diet, as compared to 142
16% in animals fed a 0.8% P1 diet. Mean increases in body wt
were 4.0 0.8, 16.2 1.0 and 18.5 1.1 g for 0.0, 0.5 and
1.0% Pi diet fed animals, respectively. It is noteworthy that a
0.5% Pi diet significantly inhibited CRG without significant
influence on body growth.
The effect of dietary variation of calcium and phosphorus on
the plasma concentration of those elements is shown in Table I.
As compared to animals fed a 0.1% calcium diet, a slight
increase in total plasma calcium was observed in animals fed a
0.6 or a 1.1% calcium diet. From these data, a weak inverse
correlation can be drawn between CRG, as assessed by kidney
wt gain and plasma calcium (r =
—0.388, P < 0.1).
Phosphorus restriction is associated with a significantly lower
plasma phosphate and high plasma calcium values. In this
experiment, a statistically significant inverse correlation can be
observed between CRG and calcemia (r =
—0.672, P < 0.01).
Effect of PTH on CRG in TPTX rats (Table 2)
PTH administration in TPTX rats enhanced CRG. This
growth—promoting effect was directly proportional to the dose
given and this influence was noted on all the CR0 parameters
x studied, Some flattening of the dose—response relationship was
apparent at PTH doses of 40 IU per day, particularly with
regard to kidney wt and RNA gains.
Overall, however, the degree of CRG seemed to be of a lesser
magnitude than in previous experiments. Kidney wt gain, for
example, reached 27.8% in animals receiving 80 IU of PTH, as
compared to maximal values of about 60% in the previous two
experiments. No significant difference in body wt was noted
between these groups. Plasma calcium expectedly increased
with PTH administration and kidney wt gain could be positively
correlated with this parameter (Fig. 3A). Plasma phosphorus
reached high levels (4.8 0.2) in nephrectomized hypopara-
thyroid rats and decreased appropriately following PTH admin-
istration. In this experiment an inverse correlation was noted
between kidney wt gain and plasma phosphorus (r = —0.743, P
<0.001).
Effect of I,25-(OH)2D on RCG in vitamin D deficient rats
Results of this experiment are shown in Table 3. Following
I ,25-(OH)2D3 administration, a dose—related stimulation of
< CRG was noted, whatever the hypertrophy parameter studied.
Replacement therapy with 40 pmole of I ,25-(OH)2D3 or more
completely normalized the degree of CR0.
A proportional increase in plasma calcium was noted, dem-
onstrating bioavailability of the hormone. Figure 3B shows that
in these animals, CRG can be correlated highly significantly
with plasma calcium. Plasma phosphorus decreased slightly in
rats given 10 and 20 pmoles of calcitriol per day, but remains
unchanged in rats receiving higher doses. No correlation was
noted between CR0 and plasma phosphorus (r = 0.103). A
slight impairment in body wt gain was observed in animals
receiving the solvent alone but no significant difference is
observed between other groups.
Effect of dietary calcium on CRGin TPTX-vitamin D
deficient rats
In an attempt to dissociate the effect of PTH and
I ,25-(OH)2D3 from their induced increase in plasma calcium,
vitamin D deficient animals were given a fixed dose of
I ,25-(OH)2D1 and were thyroparathyroidectomized. The effect
of altering dietary calcium on RCG is shown on Figure 4.
Although there was some variability in the results, low dietary
calcium decreased kidney wt gain and 3H thymidine incorpo-
ration significantly. The changes in RNA and DNA were not
statistically significant, but tended to be modified in the same
direction. Plasma calcium was significantly depressed by the
calcium free diet: 5.93 0.19 as compared to 10.7 0.5
mg/dliter (P < 0.001) for animals given the 1% calcium aliment.
Corresponding results for plasma phosphorus were 4.14 0.11
and 3.45 0.12 mt'i (P < 0.005) for calcium free and 1.0%
calcium diet fed animals, respectively.
Effect of verapamil
The effect of this calcium entry blocker on CRG is shown in
Figure 5. Significant inhibition of kidney wt gain was observed
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Fig. 1. Influence of dietary calcium on CRG as assessed by kidney wi
RNA and DNA gains, and by 3H-zhymidine incorporation. Each
column represents the mean SEM of 5 to 7 observations. , P < 0.05
and **,P <0.001 compared with rats fed 1.1% Ca diet. Symbols are for
Ca diet: 110.1%; 0.6%; 1.1%.
Kidney RNA DNA 3H-thymidine
wt incorporation
Fig. 2. Influence of dietary phosphorus on CRG. Columns illustrate the
mean SEM of 5 to 6 measurements. Symbols are: ', P < 0.05; **, P
<0.01; ***, P < 0.001 when compared with animals fed a phosphorus-
free diet. Percent Pin diet: 11 0.0; 0.5, 1.0.
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Table 1. Effect of variations of calcium or phosphorus intake on plasma calcium and phosphorus in UNI-NX rats.
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in the group of animals fed a low calcium diet. The same effect
could be observed in rats fed a high calcium diet although it did
not reach statistical significance. Similar changes could be seen
in kidney dry wts: verapamil inhibited dry wt gain by 12.0% (P
<0.05) in animals fed 0.1% calcium diet and by 7.2% (P< 0.05)
in those fed a 1.1% calcium diet. No significant difference was
noted in plasma calcium or body wt gain.
Histological examination
In addition to a larger tissue section, histological examination
of the kidneys with an enhanced CRG showed relatively little:
less glomeruli per given field, absence of abnormal cells or
infiltrate, and more mitosis in the renal epithelium. In rats with
hypercalcemia, occasional intratubular calcifications could be
seen.
Discussion
The present study shows that the degree of CRG can be
modulated by calcium and calcium—regulating hormones. A low
dietary calcium stimulated (Figure 1), whereas a low dietary
phosphorus inhibited the phenomenon (Figure 2). PTH stimu-
lated CRG in both intact [151 or TPTX animals (Table 2). A
Dietary calcium, gIJOOg 0.1 0.6 1.1 1.0 1.0
Dietary phosphorus, g/lOO g 0.8 0.8 0.8 0.0 0.5
1.0
1.0
N 7 7 7 5 5
Plasma calcium, mg/100 muter 9.61 0.07 10.09 0.09" 10.01 0.63° 15.00 0.43 11.23 0.72°
Plasma phosphorus, m 2.97 0.11 2.87 0.06 2.78 0.09 1.92 0.03 2.58 0.l7C
5
10.57 0,07d
2.58 0.09c
P < 0.01 when compared to the group of rats fed a 0.1% calcium and 0.8% phosphorus diet.
b P <0.001.
P < 0.01 when compared to the group of rats fed a 1.0% calcium and 0.5% phosphorus diet.d P <0.001.
Table 2. Influence of parathyroid hormone on CRG in thyroparathyroidectomized rats.
PTH dose, lU/day 0 10 20 40 80
Kidney wt gain, % increase 13.7 2.6 17.4 2.4 24.0 4.6° 27.1 3.4"
Kidney RNA gain, % increase 40.5 5.1 46.4 3.9 56.5 6.8 65.4 9.0"
3H thymidine incorporation, CPM x IlI3lkidney 255.0 17.0 197.0 13.0 214.0 16.0 350.0 27.0°
Plasma calcium, mg/100 mliter 4.9 0.2 5.2 0.3 . 6.4 0.7 8.4 l.0c
Plasma phosphorus, mM 4.8 0.2 4.4 0.3 3.8 0.2" 3.5 0.3C
27.8 2.4"
62.3 3.9°
463.0 74.0C
8.8 0.8C
3.3 0.IC
A B
= .723 p < 0.001
n=24
*$
60
U
A *
r= .852 p<0.OO1
n = 23
*
.
.
*
*
.
ft
40
.
U
a P < 0.05 when compared to the group of animals infused with solvent.
"P < 0.01.
P < 0.001.
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30
20
10
0 0
5
Plasma calcium, mg/loom!
Fig. 3. Relationship between kidney wt gain and plasma calcium measured at sacrifice. 3A. TPTX rats received PTH at doses of lU/day: 0, 0;
L, 10; •, 20; *, 40; A, 80. 3B. Vitamin D deficient rats were given doses of calcitriol in pmole/day: 0,0; +, 5; , 10; •, 20; , 40;•, 80.
U
U
*
30
A
A
20
+
4 7 10
10
8 11 14
700 ished—and even reversed—when calcitriol and PTH levels
were kept unchanged by constant calcitriol infusion in TPTX
600 animals (Figure 4).
Four parameters have been chosen to assess the degree of
500
><
CRG: increases in kidney wt, total RNA and DNA content of
the kidney, and 3H thymidine incorporation. These measure-
400 ments have all been widely used as indices of hypertrophy and
300 hyperplasia of the kidney (1, 21. In each experiment, the extent
of total RNA increase always exceed DNA augmentation.
200 Therefore, in our experimental set—up, alterations in calcium
homeostasis induced both hyperplastic and hypertrophic re-
100 sponses of the remaining kidney. Results obtained with radio-
labeled thymidine corroborate DNA measurements [20], and
0 even larger differences were often observed between groups.
However, thymidine precursor pools have not been measured
and differences in these pools might slightly influence the
results [41.
Is there a common mechanism that could explain all the
observations? In an attempt to answer this question, several
hypotheses must be considered:
Parathyroid hormone could well mediate the modulation of
CRG induced by alterations in dietary mineral supply. This
hormone directly stimulates CRG (15, Table 2), and its plasma
levels are both increased by calcium restriction [21, 22] and
decreased by phosphorus depletion [23]. By analogy, PTH has
also been shown to promote the liver regeneration that occurs
following partial hepatectomy [24]. From the point of view of
the renal mass regulation, PTH could even act as a regulator
since its plasma levels are elevated during renal failure [21, 25].
According to this hypothesis, a decrease in renal mass will set
a series of events resulting in a state of hyperparathyroidism
that will minimize the renal tissue loss by stimulating renal cells
to proliferate. This effect of PTH might be beneficial in the state
of acute renal tissue loss. In the long term, however, states
associated with high PTH levels might have deleterious effects
on renal function [26]. in any case, PTH does not seem to be a
likely candidate to explain all our observations: plasma PTH
levels have been shown to decrease when calcitriol is given
[27], a measure which otherwise stimulates CRG [Table 31.
Calcitonin does not seem to markedly influence CRG. Previ-
ous experiments have shown that its administration fails to
modify significantly the degree of CRG [15].
l,25-(OH)2D3 could also be a possible mediator of the
changes observed. It is well known that its production is
stimulated by both calcium restriction and parathyroid hormone
[27—30] and its administration stimulates CRG in a dose propor-
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Table 3. Influence of calcitriol on CRG in vitamin D deficient rats.
Dose of calcitriol (pmole/day) 0 5
4
10
5
20
5
40
5
80
-
3N 5
Kidney wt gain, % increase 21.7 4.3 29.9 3.3 37.6 2.0" 44.3 I.lt 56.4 8.9' 55.0 2.6°
Kidney RNA gain, % increase 30.6 3.8 33.6 1.1 42.0 5.8" 47.9 3.6' 47.0 55.8 1.4'
Kidney DNA gain, % increase 8.1 2.4 14.3 3.6 8.9 4.8 12.3 5.1 22.4 4.9 40.7 11.9'
3H-thymidine incorporation, DPM x 103/kidney 147.0 19.0 295.0 66.0' 420.0 14.0' 430.0 48.0' 450.0 16.0' 385.0 13.2'
Plasma calcium, mg/IOU muter 6.2 0.2 8.4 0.5k' 10.2 0.3' 11.0 0.4' 11.7 0.2' 12.9 0.8°
Plasma phosphorus, !nM 3.3 0.1 3.0 0.1 2.9 0.1" 2.9 0.1" 3.3 0.1 3.3 0.1
"P < 0.05 when compared to the group of animals infused with solvent.
h P <0.01.
'P <0.001.
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w(0
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5,(05,
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I I I I
Kidney RNA DNA 3H-thymidine
wt incorporation
Fig. 4. influence of dietary calcium on CRG in TPTX, vitamin D
deficient rats given a fixed dose qfcalcitriol. Hatched bars illustrate the
group of ani,nals fed a calcium free diet whereas open bars those fed a
1.0% dietar' calcium. * P < 0.001.
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Dietary calcium, g/lOOg
Fig. 5. Effect of dietary calcium and verapamil administration on CRG.
In this experiment, kidney wt gain was assessed 8 days after UNI-NX.
Each column represents the mean SEM of 5 to 6 observations.
Symbols are: E solvent; verapamil.
similar effect was also observed when 1 ,25-(OH),D3 was given
to intact (unpublished observations) or vitamin D deficient rats
(Table 3). Finally, the effect of dietary calcium were abol-
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tional manner (Table 3). Like PTH, it has been shown to
enhance liver regeneration in vitamin D deficient rats [241. It
also stimulates DNA synthesis of bone diaphysis and duode-
num [31] and enhances intestinal protein synthesis [32]. From
an homeostatic point of view however, it is difficult to sustain
that I ,25-(OH)2D3 could act as a regulator of kidney growth
since, in normal conditions, it is produced exclusively by the
kidney. In addition, its plasma level changes very little follow-
ing UNI-NX in the rat [33]. Nevertheless, with regard to our
results, the observations of Chen and Feldman on bone cells
[34] and of Provedini, Deftos and Manolagas [35] on thymus—
derived lymphocytes are very interesting: they show that the
I ,25-(OH)2D3 receptor number tends to correlate with the rate
of cell division. Assuming that the same is true for kidney cells,
it would be tempting to postulate this putative cascade of
events: contralateral nephrectomy leading to tubular cell pro-
liferation, increase in 1 ,25-(OH)2D3 receptors that would en-
hance its growth promoting effect.
The plasma level of minerals did not appear to act as common
mediators of the phenomenons observed: CRG was not consis-
tently correlated with plasma phosphorus. In the experiments
where dietary calcium or phosphorus was altered, weak inverse
correlations between CRG and plasma phosphorus were noted.
However, the reverse was true when PTH was given, and no
such correlation could be drawn from the experiment where
l,25-(OH)2D3 was given. These observations tend to discredit
the possible regulatory influence of phosphorus on CRG. It is
possible that a low dietary phosphorus inhibits CR0 by enhanc-
ing intestinal calcium absorption [36] which would diminish
PTH release. With regard to calcemia, CRG was positively
correlated with plasma calcium in animals given PTH or
l,25-(OH)2D3 and in those given different calcium diets when
the former parameters were held constant. However, the re-
verse seems to be the case in intact animals.
A hypothesis that takes into account all these observations
might be derived from the facts that PTH and I ,25-(OH)2D3 act,
at the cell level, as calcium ionophores [37, 381 with a resultant
increase in cell calcium. Cytosolic calcium, directly or by its
interaction with calmodulin, has been shown to be an important
modulator of hormone actions and cell regulation [39]. With
regard to our observations, it is interesting to note that situa-
tions in which CR0 was stimulated have been described as
being associated with elevated cytosolic calcium levels: low
dietary calcium: phosphorus ratio, PTH and l,25-(OH)2D3
administration [37, 38, 40]. Therefore one can postulate that
cytosolic calcium changes might be the common step involved
in the modulation of CR0 by calcium and calcium regulating
hormones, an increase in cytosolic calcium stimulating CRG.
However, since free cytoplasmic calcium concentration has not
been measured in this study, this hypothesis remains specula-
tive. Nevertheless, our observation that verapamil impaired
CR0 gives support to this hypothesis: when given either in vivo
[41] orin vitro [42] this calcium channel blocker has been shown
to inhibit calcium uptake by kidney slices, Therefore, this
situation is another one where the changes in the degree of CRG
seems to parallel changes in cell calcium. Further studies will be
needed to define this putative role of intracellular calcium in
both physiological or pathophysiological conditions (diabetes,
hypokalemia) of kidney epithelial cell growth.
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